SCHEMBL25682991

SCHEMBL25682991

CCCc1cc2oc3ccccc3c2c2c1c1ccccc1n2C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.40
▸ MAPT P10636 6/20 0.40
▸ SMN1; SMN2 Q16637 6/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ HPGD P15428 5/20 0.38
▸ LMNA P02545 4/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ GAA P10253 1/20 0.38
▸ TP53 P04637 4/20 0.37
▸ HTT P42858 3/20 0.36
▸ GABRP O00591 1/20 0.36
▸ GABRD O14764 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ GABRA2 P47869 1/20 0.36
▸ GABRB2 P47870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25997713 0.90 KDM4E (0.40) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL25682394 0.84 KDM4E (0.39) KDM4EMAPTSMN1; SMN2ALDH1A1LMNA
SCHEMBL25683032 0.83 KDM4E (0.39) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL25683035 0.82 GPR3 (0.39) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL25682955 0.80 ALKBH5 (0.36) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL25682835 0.79 GPR3 (0.39) KDM4EMAPTSMN1; SMN2ALDH1A1LMNA
SCHEMBL25683371 0.79 KDM4E (0.39) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL25681557 0.78 HSD17B10 (0.49) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL25993542 0.77 KDM4E (0.41) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL25682192 0.77 KDM4E (0.41) KDM4EMAPTSMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
EP-4190791-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT Kyulux, Inc. (JP) 2023-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 KDM4E 1997/4885MAPT 1225/4885SMN1; SMN2 3623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback